Early research (Phase 1)Study completedNCT01591668What this trial is testingA Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis CWho this might be right forHepatitis C Gilead Sciences 51
Not applicableStudy completedNCT01464008What this trial is testingThe Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis CWho this might be right forChronic Hepatitis C Beijing Ditan Hospital 297
Large-scale testing (Phase 3)Study completedNCT02738138What this trial is testingEvaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)Who this might be right forHepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more AbbVie 153
Early research (Phase 1)Study completedNCT00591214What this trial is testingSafety and PK Study of MP-424 to Treat Chronic Hepatitis CWho this might be right forChronic Hepatitis C Tanabe Pharma Corporation 10
Not applicableActive Not RecruitingNCT07565948What this trial is testingSofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA TreatmentWho this might be right forHepatitis C Virus (HCV) Xiangya Hospital of Central South University 200
Large-scale testing (Phase 3)Study completedNCT01783678What this trial is testingA Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected AdultsWho this might be right forChronic Hepatitis CHuman Immunodeficiency Virus Gilead Sciences 275
Testing effectiveness (Phase 2)Study completedNCT01563536What this trial is testingStudy to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected SubjectsWho this might be right forChronic Hepatitis C Infection AbbVie (prior sponsor, Abbott) 12
Not applicableStudy completedNCT02823457What this trial is testingVBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis CWho this might be right forPatient Adherence, Chronic Hepatitis C, Alcohol-related Disorders G.V. (Sonny) Montgomery VA Medical Center 20
Not applicableEnded earlyNCT00705107What this trial is testingAdherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)Who this might be right forHepatitis C, ChronicHepatitis C Merck Sharp & Dohme LLC 267
Post-approval studies (Phase 4)Study completedNCT01429792What this trial is testingA Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 1,013
Not applicableLooking for participantsNCT07095192What this trial is testingScaling Up Point-of-Care Hepatitis C Testing and Treatment in CanadaWho this might be right forHCVHEPATITIS C VIRUS CHRONIC INFECTION McGill University 300
Testing effectiveness (Phase 2)Study completedNCT01017575What this trial is testingSafety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin)Who this might be right forHepatitis C Infection Bristol-Myers Squibb 55
Not applicableStudy completedNCT03341871What this trial is testingGlecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6Who this might be right forHepatitis C Virus (HCV) AbbVie 1,095
Large-scale testing (Phase 3)Study completedNCT01846832What this trial is testingTMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV InfectionWho this might be right forHepatitis C, ChronicInfection Janssen-Cilag International NV 232
Large-scale testing (Phase 3)Study completedNCT00162734What this trial is testingDaily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined TherapyWho this might be right forChronic Hepatitis C Bausch Health Americas, Inc. 144
Not applicableStudy completedNCT02758509What this trial is testingImpact of Antiviral Therapy on Gastroesophageal Varices.Who this might be right forChronic Hepatitis CCirrhosis Parc de Salut Mar 237
Post-approval studies (Phase 4)Study completedNCT00189163What this trial is testingPioglitazone in Hepatitis CWho this might be right forChronic Hepatitis C University of Michigan 40
Early research (Phase 1)Study completedNCT03430830What this trial is testingEvaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in ChinaWho this might be right forChronic Hepatitis c Ascletis Pharmaceuticals Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT01995071What this trial is testingEvaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)Who this might be right forChronic Hepatitis CHepatitis C VirusCompensated Cirrhosis AbbVie 89
Post-approval studies (Phase 4)UnknownNCT02745132What this trial is testingCognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)Who this might be right forHepatitis C Instituto de Investigación Marqués de Valdecilla 80